VIR Vir Biotechnology, Inc. - Common Stock
$9,95
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$4–$12
77% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$21
+111% upside
P/E (TTM)
-3.6
ROE
-51.1%
Nettogewinnmarge
-638.9%
Über Vir Biotechnology, Inc. - Common Stock Unternehmensübersicht von Wikipedia
VIR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.95
Marktkapitalisierung
$1.60B
P/E (TTM)
-3.6
EPS (TTM)
$-3.16
Umsatz (TTM)
$69M
Dividendenrendite
—
ROE
-51.1%
Verschuldungsgrad
—
52W-Spanne
$4 – $12
VIR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$69M
2017-12-31
→
2025-12-31
EPS
$-3.16
2019-12-31
→
2025-12-31
Freier Cashflow
$-397M
2019-12-31
→
2025-12-31
Margen
-638.9%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
VIR
Peer-Median
P/E (TTM)
-3.6
—
P/S (TTM) (K/V (TTM))
23.4
22.4
P/B (K/B)
2.1
2.7
Price / FCF (Kurs / FCF)
-4.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
VIR
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-699.2%
—
Net Profit Margin (Nettogewinnmarge)
-638.9%
-638.9%
ROA
-36.5%
-43.1%
ROE
-51.1%
-49.0%
ROIC
-62.7%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
VIR
Peer-Median
Current Ratio (Liquiditätsgrad)
5.5
9.0
Quick Ratio
5.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
VIR
Peer-Median
Revenue YoY (Umsatz YoY)
-7.6%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-65.1%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
-2.1%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
VIR
Peer-Median
VIR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 4 28,6%
- Kauf 9 64,3%
- Halten 1 7,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-17
Median
$20.00
← Unter allen Zielen
$9.95
Tief
$15.00
Hoch
$30.00
Median-Ziel
$20.00
+101,0%
Mittelwert-Ziel
$21.00
+111,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.14%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.47 | $0.34 | 0.13% |
| 31. März 2026 | $-0.85 | $-0.10 | -0.75% |
| 31. Dezember 2025 | $-0.31 | $-0.50 | 0.19% |
| 30. September 2025 | $-1.17 | $-0.86 | -0.31% |
| 30. Juni 2025 | $-0.80 | $-0.73 | -0.07% |
| 31. März 2025 | $-0.88 | $-0.84 | -0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| TRAX | — | — | — | — | — | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| PURR | — | — | — | — | — | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| AKTS | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | $11M | |
| Cost of Revenue | $26.0K | $845.0K | $3M | $146M | $66M | $0 | $0 | · | |
| R&D Expense | $456M | $506M | $580M | $475M | $448M | $302M | $148M | $100M | |
| SG&A Expense | $92M | $119M | $174M | $162M | $161M | $71M | $38M | $29M | |
| Operating Expenses | $548M | $661M | $770M | $783M | $675M | $373M | $186M | $129M | |
| Operating Income | $-479M | $-587M | $-684M | $833M | $421M | $-297M | $-178M | $-119M | |
| Interest Income | $40M | $72M | $87M | $28M | · | · | $9M | $3M | |
| Other Non-op | $-409.0K | $-2M | $-9M | $4M | $-9M | $-4M | $-5M | $-212.0K | |
| Pretax Income | $-438M | $-523M | $-628M | $754M | $550M | $-299M | $-175M | $-116M | |
| Income Tax | $217.0K | $-1M | $-13M | $238M | $21M | $54.0K | $154.0K | $-480.0K | |
| Net Income | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | $-116M | |
| EPS (Basic) | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | · | |
| EPS (Diluted) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · | |
| Shares (Basic) | 138,520,419 | 136,246,865 | 134,130,924 | 132,606,767 | 129,884,967 | 119,159,424 | 30,349,920 | · | |
| Shares (Diluted) | 138,520,419 | 136,246,865 | 134,130,924 | 134,810,908 | 133,437,126 | 119,159,424 | 30,349,920 | · | |
| EBITDA | $-468M | $-573M | $-665M | $839M | $426M | $-293M | $-175M | · |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $232M | $223M | $242M | $849M | $348M | $437M | $109M | $48M | |
| Short-term Investments | $229M | $678M | $1.27B | $1.52B | $217M | $300M | $274M | $51M | |
| Receivables | · | · | · | $0 | $773M | $0 | · | · | |
| Prepaid Expense | $45M | $48M | $53M | $104M | $73M | $28M | $13M | $9M | |
| Other Current Assets | · | $100.0K | $8M | $26M | · | · | · | · | |
| Current Assets | $514M | $1.04B | $1.59B | $2.52B | $1.56B | $772M | $403M | $118M | |
| PP&E (Net) | $56M | $63M | $96M | $106M | $43M | $18M | $16M | $12M | |
| PP&E (Gross) | $103M | $100M | $130M | $126M | $57M | $27M | $21M | $14M | |
| Accum. Depreciation | $47M | $37M | $34M | $21M | $14M | $9M | $5M | $2M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $8M | $8M | $23M | $33M | $33M | $34M | $36M | $37M | |
| Total Assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Accounts Payable | $10M | $5M | $6M | $6M | $7M | $5M | $6M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | $26M | $15M | |
| Current Liabilities | $93M | $120M | $175M | $511M | $341M | $99M | $59M | $40M | |
| Capital Leases | $89M | $90M | $112M | $124M | $134M | $67M | · | · | |
| Deferred Tax | · | · | · | $3M | $18M | $3M | $3M | · | |
| Other Non-current Liabilities | $22M | $15M | $16M | $11M | $3M | $4M | $4M | $2M | |
| Total Liabilities | $238M | $248M | $329M | $724M | $522M | $202M | $88M | $62M | |
| Common Stock | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $11.0K | $1.0K | |
| Paid-in Capital | $1.97B | $1.91B | $1.83B | $1.71B | $1.57B | $1.39B | $793M | $15M | |
| Retained Earnings | $-1.20B | $-760M | $-238M | $377M | $-139M | $-667M | $-369M | $-194M | |
| AOCI | $-2M | $-2M | $-815.0K | $-9M | $-1M | $-1M | $-601.0K | $-14.0K | |
| Stockholders' Equity | $765M | $1.15B | $1.59B | $2.08B | $1.43B | $717M | $424M | $-179M | |
| Liabilities + Equity | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Shares Outstanding | 139,474,954 | 136,959,446 | 134,781,286 | 133,236,687 | 131,161,404 | 127,416,740 | 107,648,925 | 8,858,799 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $15M | $19M | $7M | $5M | $4M | $3M | $2M | |
| Stock-based Comp | $49M | $78M | $111M | $102M | $84M | $28M | $9M | $5M | |
| Deferred Tax | $304.0K | $-3M | $-1M | $-15M | $15M | $-52.0K | · | $-500.0K | |
| Amort. of Intangibles | · | · | $531.0K | $532.0K | $533.0K | $1M | $1M | $1M | |
| Restructuring | · | $35M | $14M | · | · | · | · | · | |
| Other Non-cash | $-15M | $-14M | $-293M | $1.05B | $-680M | $76M | $33M | · | |
| Operating Cash Flow | $-392M | $-446M | $-779M | $1.66B | $-48M | $-191M | $-130M | $-94M | |
| CapEx | $5M | $7M | $22M | $68M | $22M | $7M | $9M | $8M | |
| Investing Cash Flow | $310M | $499M | $165M | $-1.19B | $-141M | $-10M | $-256M | $-60M | |
| Stock Issued | · | · | · | $0 | $0 | $323M | $126M | · | |
| Net Stock Activity | · | · | · | $0 | · | $323M | $126M | · | |
| Financing Cash Flow | $4M | $4M | $7M | $35M | $100M | $529M | $449M | $25M | |
| Net Change in Cash | $-78M | $57M | $-607M | $505M | $-88M | $329M | $63M | $-130M | |
| Taxes Paid | $2M | $786.0K | $3M | $-252M | $0 | $0 | · | · | |
| Free Cash Flow | $-397M | $-454M | $-800M | $1.60B | $-69M | $-197M | $-139M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% | -388.9% | -2199.7% | · | |
| Net Margin | -638.9% | -703.4% | -713.8% | 31.9% | 48.2% | -391.1% | -2159.0% | · | |
| Pretax Margin | -638.6% | -705.0% | -728.9% | 46.7% | 50.2% | -391.0% | -2157.1% | · | |
| EBITDA Margin | -682.1% | -771.6% | -772.1% | 51.9% | 38.9% | -383.1% | -2159.0% | · | |
| ROA | -36.5% | -31.5% | -26.1% | 21.7% | 36.8% | -41.8% | -49.6% | · | |
| ROE | -51.1% | -43.7% | -37.7% | 24.4% | 45.8% | -39.1% | -244.1% | · | |
| ROIC | -62.7% | -50.9% | -42.1% | 27.4% | 28.2% | -41.4% | -42.0% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 | 7.8 | 6.8 | · | |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 | 7.4 | 6.5 | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.7 | 0.8 | 0.1 | 0.0 | · | |
| Receivables Turnover | · | · | · | 4.2 | 2.8 | · | · | · |
Wachstumsraten 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.6% | -13.9% | -94.7% | 47.5% | 1334.4% | · | · | · | |
| Revenue CAGR 3Y | -65.1% | -59.2% | 4.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -3.3% | · | · | · | · | |
| Net Income YoY | · | · | · | -2.4% | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | · | |
| Net Income TTM | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | · | |
| Market Cap | $841M | $1.01B | $1.36B | $3.37B | $5.49B | $3.41B | $1.35B | · | |
| P/E | -1.9 | -1.9 | -2.2 | 6.6 | 10.6 | -10.7 | -2.2 | · | |
| P/S | 12.3 | 13.5 | 15.7 | 2.1 | 5.0 | 44.7 | 167.3 | · | |
| P/B | 1.1 | 0.9 | 0.9 | 1.6 | 3.8 | 4.8 | 3.2 | · | |
| P / Tangible Book | 1.1 | 0.9 | 0.9 | 1.7 | 4.0 | 5.1 | · | · | |
| P / Cash Flow | -2.1 | -2.3 | -1.7 | 2.0 | -115.4 | -17.9 | -10.4 | · | |
| P / FCF | -2.1 | -2.2 | -1.7 | 2.1 | -79.1 | -17.3 | -9.8 | · | |
| Earnings Yield | -52.4% | -52.2% | -45.6% | 15.1% | 9.5% | -9.4% | -45.8% | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239M | $-29.0K | $64M | $240.0K | $1M | $3M | $12M | $2M | $3M | $56M | $17M | $3M | $4M | $63M | $49M | $375M | |
| Cost of Revenue | $0 | · | · | · | $11.0K | $0 | $684.0K | $50.0K | $52.0K | $59.0K | $798.0K | $38.0K | $22.0K | $2M | $6M | $22M | |
| R&D Expense | $135M | $109M | $88M | $151M | $98M | $119M | $106M | $195M | $105M | $100M | $109M | $145M | $168M | $158M | $155M | $114M | |
| SG&A Expense | $30M | $23M | $24M | $22M | $22M | $24M | $27M | $26M | $30M | $36M | $41M | $41M | $46M | $47M | $39M | $43M | |
| Operating Expenses | $165M | $132M | $112M | $174M | $120M | $143M | $130M | $234M | $162M | $136M | $156M | $189M | $219M | $206M | $200M | $180M | |
| Operating Income | $73M | $-132M | $-48M | $-173M | $-118M | $-140M | $-117M | $-231M | $-159M | $-80M | $-139M | $-187M | $-215M | $-143M | $-151M | $195M | |
| Interest Income | $9M | $7M | $8M | $9M | $11M | $12M | $14M | $18M | $19M | $21M | $21M | $22M | · | · | · | · | |
| Other Non-op | $-451.0K | $-254.0K | $-335.0K | $-228.0K | $226.0K | $-72.0K | $-506.0K | $-893.0K | $-535.0K | $-287.0K | $-1M | $882.0K | $-367.0K | $-8M | $-26M | $27M | |
| Pretax Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-140M | $-65M | $-121M | $-167M | $-198M | $-143M | $-152M | $218M | |
| Income Tax | $179.0K | $170.0K | $-137.0K | $168.0K | $170.0K | $16.0K | $-86.0K | $177.0K | $-2M | $276.0K | $-5M | $-3M | $-3M | $-2M | $-50M | $42M | |
| Net Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-138M | $-65M | $-116M | $-163M | $-195M | $-141M | $-102M | $175M | |
| EPS (Basic) | $0.48 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.78 | $1.32 | |
| EPS (Diluted) | $0.47 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.74 | $1.30 | |
| Shares (Basic) | 167,719,015 | 147,356,811 | -276,326,123 | 138,930,173 | 138,447,469 | 137,468,900 | -271,911,261 | 136,653,753 | 136,223,725 | 135,280,648 | -267,770,614 | 134,289,620 | 134,059,079 | 133,552,839 | -264,652,172 | 132,729,530 | |
| Shares (Diluted) | 168,879,127 | 147,356,811 | -276,326,123 | 138,930,173 | 138,447,469 | 137,468,900 | -271,911,261 | 136,653,753 | 136,223,725 | 135,280,648 | -267,770,614 | 134,289,620 | 134,059,079 | 133,552,839 | -267,138,194 | 134,963,317 | |
| EBITDA | $73M | $-129M | · | $-173M | $-118M | $-137M | · | $-231M | $-159M | $-76M | · | $-182M | $-211M | $-138M | · | $197M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $279M | $274M | $232M | $170M | $211M | $274M | $223M | $168M | $297M | $161M | $242M | $452M | $667M | $825M | $849M | $964M | |
| Short-term Investments | $250M | $196M | $229M | $328M | $388M | $517M | $678M | $741M | $850M | $985M | · | $1.23B | $1.17B | $1.41B | · | $1.36B | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $39M | $45M | $45M | $37M | $41M | $42M | $48M | $43M | $41M | $50M | · | $59M | $86M | $98M | · | $54M | |
| Other Current Assets | · | · | · | · | · | · | · | $0 | $1M | $4M | · | $5M | $13M | $18M | · | · | |
| Current Assets | $574M | $523M | $514M | $546M | $736M | $932M | $1.04B | $1.05B | $1.21B | $1.21B | · | $1.77B | $1.95B | $2.36B | · | $2.41B | |
| PP&E (Net) | $50M | $53M | $56M | $58M | $61M | $62M | $63M | $65M | $66M | $92M | · | $99M | $104M | $104M | · | $100M | |
| PP&E (Gross) | $103M | $103M | $103M | $103M | $102M | $101M | $100M | $100M | $99M | $131M | · | $129M | $130M | $130M | · | $119M | |
| Accum. Depreciation | $53M | $50M | $47M | $44M | $42M | $39M | $37M | $35M | $33M | $38M | · | $30M | $26M | $26M | · | $19M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $19M | $19M | $22M | · | $25M | $26M | $33M | · | $33M | |
| Total Assets | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Accounts Payable | $18M | $5M | $10M | $7M | $12M | $4M | $5M | $7M | $4M | $7M | · | $4M | $12M | $12M | · | $3M | |
| Current Liabilities | $95M | $74M | $93M | $75M | $105M | $137M | $120M | $117M | $96M | $94M | · | $165M | $226M | $485M | · | $308M | |
| Capital Leases | $84M | $87M | $89M | $91M | $93M | $88M | $90M | $93M | $95M | $109M | · | $114M | $118M | $121M | · | $127M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | $18M | |
| Other Non-current Liabilities | $19M | $19M | $22M | $13M | $13M | $15M | $15M | $14M | $14M | $14M | · | $13M | $12M | $8M | · | $7M | |
| Total Liabilities | $232M | $213M | $238M | $223M | $245M | $264M | $248M | $258M | $236M | $247M | · | $370M | $434M | $695M | · | $546M | |
| Common Stock | $17.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Paid-in Capital | $2.23B | $2.14B | $1.97B | $1.95B | $1.94B | $1.93B | $1.91B | $1.89B | $1.88B | $1.85B | · | $1.80B | $1.77B | $1.74B | · | $1.68B | |
| Retained Earnings | $-1.24B | $-1.32B | $-1.20B | $-1.15B | $-992M | $-881M | $-760M | $-655M | $-441M | $-303M | · | $-122M | $42M | $236M | · | $479M | |
| AOCI | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $1M | $-3M | $-2M | · | $-2M | $-3M | $-3M | · | $-12M | |
| Stockholders' Equity | $982M | $813M | $765M | $796M | $947M | $1.04B | $1.15B | $1.24B | $1.43B | $1.55B | $1.59B | $1.68B | $1.81B | $1.97B | $2.08B | $2.15B | |
| Liabilities + Equity | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Shares Outstanding | 169,185,671 | 161,234,058 | 139,474,954 | 139,022,594 | 138,886,274 | 138,063,698 | 136,959,446 | 136,706,350 | 136,590,097 | 135,843,560 | 134,781,286 | 134,497,886 | 134,230,494 | 133,930,957 | 133,236,687 | 133,027,358 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $4M | $5M | $6M | $2M | $2M | |
| Stock-based Comp | $12M | $12M | $11M | $11M | $12M | $14M | $16M | $17M | $22M | $24M | $28M | $27M | $31M | $25M | $25M | $25M | |
| Deferred Tax | · | · | · | · | · | · | $-3M | $57.0K | · | · | $-1M | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $133.0K | $133.0K | $133.0K | · | $133.0K | |
| Restructuring | · | · | · | · | · | · | $-4M | $13M | $26M | $-48.0K | · | · | · | · | · | · | |
| Other Non-cash | · | $-22M | · | · | · | $26M | · | · | · | $-72M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $123M | $-132M | $-26M | $-168M | $-120M | $-78M | $-88M | $-171M | $-78M | $-109M | $-108M | $-156M | $-389M | $-126M | $35M | $118M | |
| CapEx | $32.0K | $390.0K | $348.0K | $317.0K | $3M | $2M | $2M | $3M | $666.0K | $2M | $2M | $4M | $9M | $7M | $13M | $19M | |
| Investing Cash Flow | $-197M | $12M | $87M | $40M | $56M | $127M | $141M | $119M | $212M | $28M | $-105M | $-59M | $230M | $98M | $-153M | $-663M | |
| Stock Issued | · | $162M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $162M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $78M | $163M | $1M | $102.0K | $2M | $598.0K | $1M | $31.0K | $3M | $152.0K | $2M | $277.0K | $3M | $2M | $2M | $2M | |
| Net Change in Cash | $5M | $42M | $62M | $-127M | $-62M | $49M | $54M | $-53M | $137M | $-81M | $-211M | $-215M | $-156M | $-25M | $-116M | $-543M | |
| Taxes Paid | · | · | $154.0K | $5M | · | · | · | $0 | · | · | · | · | · | · | $-444M | $102M | |
| Free Cash Flow | · | $-133M | · | · | · | $-80M | · | · | · | $-111M | · | · | · | $-133M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.8% | 456172.4% | · | -72267.9% | -9754.3% | -4602.5% | · | -9718.7% | -5158.7% | -142.1% | · | -7075.9% | -5667.3% | -227.7% | · | 52.0% | |
| Net Margin | 33.5% | 433431.0% | · | -67975.4% | -9139.9% | -3989.6% | · | -8979.7% | -4500.1% | -115.8% | · | -6192.2% | -5129.7% | -223.9% | · | 46.8% | |
| Pretax Margin | 33.6% | 432844.8% | · | -67905.4% | -9125.9% | -3989.1% | · | -8972.3% | -4549.3% | -115.3% | · | -6314.0% | -5204.7% | -227.4% | · | 58.1% | |
| EBITDA Margin | 30.8% | 446479.3% | · | -72267.9% | -9754.3% | -4507.9% | · | -9718.7% | -5158.7% | -134.0% | · | -6905.3% | -5546.1% | -219.0% | · | 52.5% | |
| ROA | 6.7% | -10.8% | · | -13.0% | -7.8% | -7.8% | · | -12.1% | -7.1% | -2.9% | · | -6.9% | -8.0% | -5.1% | · | 9.0% | |
| ROE | 8.3% | -13.5% | · | -16.0% | -9.3% | -9.3% | · | -14.7% | -8.5% | -3.7% | · | -8.5% | -10.3% | -7.1% | · | 11.6% | |
| ROIC | 7.5% | -16.3% | · | -21.8% | -12.5% | -13.4% | · | -18.7% | -10.9% | -5.2% | · | -10.9% | -11.7% | -7.2% | · | 7.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 7.1 | · | 7.3 | 7.0 | 6.8 | · | 8.9 | 12.5 | 12.9 | · | 10.7 | 8.6 | 4.9 | · | 7.8 | |
| Quick Ratio | 5.6 | 6.4 | · | 6.6 | 5.7 | 5.8 | · | 7.8 | 11.9 | 12.2 | · | 10.2 | 8.1 | 4.6 | · | 7.5 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.1 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $240M | $4M | · | $7M | $10M | $65M | · | $64M | $66M | $126M | · | $444M | $401M | $1.63B | · | $1.67B | |
| Net Income TTM | $-320M | $-521M | · | $-609M | $-584M | $-538M | · | $-581M | $-562M | $-564M | · | $-324M | $-237M | $476M | · | $728M | |
| Market Cap | $1.72B | $1.44B | · | $794M | $700M | $895M | · | $1.02B | $1.22B | $1.38B | · | $1.26B | $3.29B | $3.12B | · | $2.56B | |
| P/E | -4.3 | -2.4 | · | -1.3 | -1.2 | -1.6 | · | -1.8 | -2.1 | -2.4 | · | -3.9 | -13.7 | 6.6 | · | 3.6 | |
| P/S | 7.2 | 324.1 | · | 115.6 | 72.2 | 13.8 | · | 15.9 | 18.5 | 10.9 | · | 2.8 | 8.2 | 1.9 | · | 1.5 | |
| P/B | 1.8 | 1.8 | · | 1.0 | 0.7 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 0.8 | 1.8 | 1.6 | · | 1.2 | |
| P / Tangible Book | 1.8 | 1.8 | · | 1.0 | 0.8 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.9 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -10.9 | · | · | · | -11.5 | · | · | · | -12.6 | · | · | · | -24.8 | · | · | |
| P / FCF | · | -10.9 | · | · | · | -11.2 | · | · | · | -12.4 | · | · | · | -23.5 | · | · | |
| Earnings Yield | -23.1% | -41.3% | · | -77.2% | -84.5% | -60.8% | · | -57.1% | -46.9% | -41.6% | · | -25.9% | -7.3% | 15.1% | · | 28.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $69M | $74M | $86M | $1.62B | $1.10B |
| Betriebsgewinnmarge % | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% |
| Nettoergebnis | $-438M | $-522M | $-615M | $516M | $529M |
| Verwässerte EPS | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-397M | $-454M | $-800M | $1.60B | $-69M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Warum ein Biotech-Fonds eine neue Position von 6 Millionen Dollar in Vir mit einem 99%-igen Aktienkursanstieg eröffnet hat
- Vir Biotechnology's Vorstandsvorsitzender verkaufte 22.000 Unternehmensaktien. Hier ist, was das für Investoren bedeutet.
- Ist Vir Biotechnology, Inc. (VIR) eine gute Aktie, die man jetzt kaufen sollte?
- Vir Biotechnology (VIR) CEO verkauft 73.000 Aktien für 664.000 US-Dollar
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 259 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (-26 vs. Vorquartal) | 41 (+14 vs. Vorquartal) | 87 (-24 vs. Vorquartal) | 75 (+29 vs. Vorquartal) | +21.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $129.353.521 | 12.694.163 | 11,11% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.136.241 | 11.495.215 | 10,06% | Aktien |
| SB INVESTMENT ADVISERS (UK) LTD | $111.561.068 | 10.948.093 | 9,59% | Aktien |
| STATE STREET CORP | $101.534.699 | 9.964.151 | 8,72% | Aktien |
| GSK plc | $87.134.221 | 8.550.954 | 7,49% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $65.101.617 | 6.388.775 | 5,59% | Aktien |
| Point72 Asset Management, L.P. | $57.744.906 | 5.666.821 | 4,96% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $29.728.265 | 2.917.396 | 2,55% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $29.394.674 | 2.884.182 | 2,53% | Aktien |
| ADAR1 Capital Management, LLC | $25.033.539 | 2.456.677 | 2,15% | Aktien |
| GOLDMAN SACHS GROUP INC | $22.206.109 | 2.179.206 | 1,91% | Aktien |
| Pictet Asset Management Holding SA | $19.904.290 | 1.953.316 | 1,71% | Aktien |
| Boxer Capital Management, LLC | $19.014.540 | 1.866.000 | 1,63% | Aktien |
| Hudson Bay Capital Management LP | $13.899.160 | 1.364.000 | 1,19% | Aktien |
| GordonMD Global Investments LP | $13.792.695 | 1.353.552 | 1,19% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.483.255 | 1.323.185 | 1,16% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.313.213 | 1.110.227 | 0,97% | Aktien |
| Sio Capital Management, LLC | $10.957.042 | 1.075.274 | 0,94% | Aktien |
| Savvy Advisors, Inc. | $10.604.376 | 1.040.665 | 0,91% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $10.361.844 | 1.016.864 | 0,89% | Aktien |
| Soleus Capital Management, L.P. | $10.190.000 | 1.000.000 | 0,88% | Aktien |
| BANK OF AMERICA CORP /DE/ | $9.670.045 | 948.974 | 0,83% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8.699.050 | 853.685 | 0,75% | Aktien |
| FMR LLC | $8.624.011 | 846.321 | 0,74% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $8.575.466 | 841.557 | 0,74% | Aktien |
| Ensign Peak Advisors, Inc | $8.496.208 | 833.779 | 0,73% | Aktien |
| ALGERT GLOBAL LLC | $8.202.716 | 804.977 | 0,70% | Aktien |
| Saturn V Capital Management LP | $7.852.852 | 770.643 | 0,67% | Aktien |
| CITADEL ADVISORS LLC | $7.698.402 | 755.486 | 0,66% | Aktien |
| JPMORGAN CHASE & CO | $7.529.071 | 725.344 | 0,65% | Aktien |
| Jones Hill Capital LP | $6.717.380 | 659.213 | 0,58% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $6.661.121 | 653.692 | 0,57% | Aktien |
| Qube Research & Technologies Ltd | $6.536.742 | 641.486 | 0,56% | Aktien |
| Candriam S.C.A. | $6.379.827 | 626.690 | 0,55% | Aktien |
| Clearstead Advisors, LLC | $6.197.906 | 608.234 | 0,53% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $5.954.037 | 584.302 | 0,51% | Aktien |
| Weiss Asset Management LP | $5.660.963 | 555.541 | 0,49% | Aktien |
| Avidity Partners Management LP | $5.291.667 | 519.300 | 0,45% | Aktien |
| Walleye Capital LLC | $5.240.218 | 514.251 | 0,45% | Aktien |
| Alta Partners Management Company, L.P. | $5.196.054 | 509.917 | 0,45% | Aktien |
| Parkman Healthcare Partners LLC | $4.843.093 | 475.279 | 0,42% | Aktien |
| Jump Financial, LLC | $4.673.857 | 458.671 | 0,40% | Aktien |
| Public Sector Pension Investment Board | $4.251.360 | 417.209 | 0,37% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $3.813.760 | 374.265 | 0,33% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $3.556.514 | 349.020 | 0,31% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $3.521.063 | 345.541 | 0,30% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.483.531 | 577.700 | 0,30% | Aktien |
| Corient Private Wealth LP | $3.164.542 | 310.548 | 0,27% | Aktien |
| RHUMBLINE ADVISERS | $2.905.698 | 285.154 | 0,25% | Aktien |
| Swiss National Bank | $2.389.555 | 234.500 | 0,21% | Aktien |
| Birchview Capital, LP | $2.241.800 | 220.000 | 0,19% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.186.051 | 214.529 | 0,19% | Aktien |
| CITIGROUP INC | $2.153.402 | 211.325 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.075.458 | 203.676 | 0,18% | Aktien |
| BlackRock, Inc. | $2.069.752 | 203.116 | 0,18% | Aktien |
| D. E. Shaw & Co., Inc. | $2.010.935 | 197.344 | 0,17% | Aktien |
| Hillsdale Investment Management Inc. | $1.907.527 | 187.196 | 0,16% | Aktien |
| Legal & General Group Plc | $1.893.607 | 185.830 | 0,16% | Aktien |
| Erste Asset Management GmbH | $1.876.704 | 180.800 | 0,16% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.842.444 | 180.809 | 0,16% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $1.702.437 | 165.768 | 0,15% | Aktien |
| Eversept Partners, LP | $1.596.121 | 156.636 | 0,14% | Aktien |
| WINTON GROUP Ltd | $1.564.073 | 153.491 | 0,13% | Aktien |
| OP Asset Management Ltd | $1.551.499 | 152.257 | 0,13% | Aktien |
| Man Group plc | $1.535.511 | 150.688 | 0,13% | Aktien |
| Rafferty Asset Management, LLC | $1.400.809 | 137.469 | 0,12% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.389.254 | 136.335 | 0,12% | Aktien |
| Edgestream Partners, L.P. | $1.368.731 | 134.321 | 0,12% | Aktien |
| DEUTSCHE BANK AG\ | $1.368.089 | 134.258 | 0,12% | Aktien |
| Engineers Gate Manager LP | $1.308.671 | 128.427 | 0,11% | Aktien |
| Quantinno Capital Management LP | $1.303.556 | 127.925 | 0,11% | Aktien |
| Squarepoint Ops LLC | $1.285.377 | 126.141 | 0,11% | Aktien |
| PRUDENTIAL FINANCIAL INC | $1.281.005 | 125.712 | 0,11% | Aktien |
| Raiffeisen Bank International AG | $1.245.600 | 120.000 | 0,11% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.218.470 | 135.990 | 0,10% | Aktien |
| Empyrean Capital Partners, LP | $1.161.660 | 114.000 | 0,10% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.100.428 | 107.991 | 0,09% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.017.981 | 99.900 | 0,09% | Kaufoption |
| NOMURA HOLDINGS INC | $979.259 | 96.100 | 0,08% | Kaufoption |
| NOMURA HOLDINGS INC | $979.259 | 96.100 | 0,08% | Verkaufsoption |
| Nuveen, LLC | $913.829 | 89.679 | 0,08% | Aktien |
| Trexquant Investment LP | $869.717 | 85.350 | 0,07% | Aktien |
| BIT Capital GmbH | $815.200 | 80.000 | 0,07% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $783.896 | 76.928 | 0,07% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $782.880 | 87.375 | 0,07% | Aktien |
| MORGAN STANLEY | $770.242 | 75.588 | 0,07% | Aktien |
| Schonfeld Strategic Advisors LLC | $753.182 | 73.914 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $744.655 | 73.077 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $731.866 | 71.822 | 0,06% | Aktien |
| Quinn Opportunity Partners LLC | $723.245 | 70.976 | 0,06% | Aktien |
| Illinois Municipal Retirement Fund | $702.529 | 68.943 | 0,06% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $695.672 | 68.270 | 0,06% | Aktien |
| LMR Partners LLP | $690.882 | 67.800 | 0,06% | Aktien |
| IEQ CAPITAL, LLC | $678.318 | 66.567 | 0,06% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $655.217 | 64.300 | 0,06% | Aktien |
| Headlands Technologies LLC | $655.207 | 64.299 | 0,06% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $596.156 | 58.504 | 0,05% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $585.599 | 57.468 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $543.127 | 53.300 | 0,05% | Kaufoption |
| Louisiana State Employees Retirement System | $542.108 | 53.200 | 0,05% | Aktien |
Unternehmensinsider 27 Insider · 11 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marianne De Backer | Chief Executive Officer | 3. April 2023 A | 576.452 | 0 | 0 | $0 |
| Sung Lee | Chief Financial Officer | 27. März 2023 A | 66.500 | 0 | 0 | $0 |
| Howard Horn | CFO | 23. Februar 2023 S | 230.712 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | EVP & Chief Operating Officer | 3. März 2023 S | 148.518 | 0 | 0 | $0 |
| Brent Sabatini | SVP, Chief Accounting Officer | 1. Juni 2026 S | 61.902 | 0 | 1 | $-3.582 |
| Mark Eisner | EVP and Chief Medical Officer | 15. Juli 2024 A | 75.000 | 0 | 0 | $0 |
| Phillip Pang | Chief Medical Officer | 7. Juni 2023 M | 188.000 | 0 | 0 | $0 |
| Steven J. Rice | Chief Administrative Officer | 1. Juni 2023 S | 106.840 | 0 | 0 | $0 |
| Ann M. Hanly | Chief Technology Officer | 30. März 2023 S | 114.576 | 0 | 0 | $0 |
| Herbert Virgin | EVP, Research & CSO | 9. August 2022 M | 262.500 | 0 | 0 | $0 |
| Jay Parrish | Chief Business Officer | 1. April 2021 M | 9.260 | 0 | 0 | $0 |
| Timothy Coughlin | Direktor | 9. Juni 2026 A | 16.000 | 0 | 0 | $0 |
| Janet Napolitano | Direktor | 1. Juni 2026 S | 21.216 | 0 | 1 | $-30.240 |
| Vicki L Sato | Direktor | 2. September 2025 S | 1.254.391 | 0 | 1 | $-109.780 |
| George A Scangos | Direktor | 15. September 2023 J | 0 | 0 | 0 | $0 |
| Saira Ramasastry | Direktor | 1. Juni 2023 S | 10.619 | 0 | 0 | $0 |
| Charles Elliott Sigal | Direktor | 22. Mai 2023 A | 15.806 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Direktor | 22. Mai 2023 A | 15.806 | 0 | 0 | $0 |
| Robert J Perez | Direktor | 22. Mai 2023 A | 15.806 | 0 | 0 | $0 |
| SHARP PHILLIP A | Direktor | 22. Mai 2023 A | 121.174 | 0 | 0 | $0 |
| Robert Nelsen | Direktor | 22. Mai 2023 A | 576.148 | 0 | 0 | $0 |
| Dipchand Nishar | Direktor | 21. Mai 2021 A | 3.374 | 0 | 0 | $0 |
| Kristina Burow | Direktor | 21. Mai 2020 A | 1.000.000 | 0 | 0 | $0 |
| Klaus Frueh | Direktor | 16. Oktober 2019 C | 362.844 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10%-Eigentümer | 16. Oktober 2019 C | 2.777.777 | 0 | 0 | $0 |
| Alaska Permanent Fund Corp | 10%-Eigentümer | 16. Oktober 2019 C | 5.555.556 | 0 | 0 | $0 |
| Robert J More | — | 11. August 2026 J | 517.917 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee ×8 Einreichungen | 3. März 2026 | 8,50% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 58 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,28% | 289.265 SH | 8. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 1,13% | 41.256 NS | 30. April 2026 | N-PORT |
| GNOM · Global X Funds | 1,11% | 64.900 NS | 31. Mai 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,54% | 105.388 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,28% | 144.675 NS | 30. April 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,15% | 47.997 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 9.180 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,10% | 283.217 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 980.934 SH | 8. August 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,08% | 152.022 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 106.919 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,08% | 5.810 NS | 31. Mai 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,07% | 20.835 SH | 8. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,07% | 423.304 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,07% | 1.139.596 SH | 8. August 2026 | Täglich |
| IJS · iShares Trust | 0,07% | 634.168 SH | 8. August 2026 | Täglich |
| XJR · iShares Trust | 0,07% | 14.270 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 208.762 SH | 8. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,06% | 59.262 SH | 8. August 2026 | Täglich |
| IJR · iShares Trust | 0,06% | 7.409.402 SH | 8. August 2026 | Täglich |
| IJT · iShares Trust | 0,05% | 462.543 SH | 8. August 2026 | Täglich |
| SAA · ProShares Trust | 0,05% | 1.348 NS | 31. Mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 2.019.005 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 79.032 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 707.200 SH | 8. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,04% | 4.731 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 527.512 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 3.091.124 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 40.443 NS | 30. April 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 13.104 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 539.334 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 4.393 NS | 31. Mai 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.484.960 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 352.449 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 54.198 NS | 30. April 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 13.735 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,02% | 5.053 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 15.618 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 3.436 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 4.496 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.398.053 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 3.473 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 6.203 SH | 8. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,01% | 21.831 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 66.676 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4.363 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 10.345 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 207.815 NS | 30. April 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,00% | 10.075 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 87 NS | 31. Mai 2026 | N-PORT |